Filters
Hikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USP
Press Release, Product
Hikma launches Diazepam Injection, USP in the US
Press Release, Product
Good momentum across all businesses and updated Generics guidance
Press Release, Financial Results
Hikma launches Regadenoson Injection in prefilled syringe
Press Release, Product
Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLC
Press Release, Inside Information
Hikma launches Posaconazole Oral Suspension in the US
Press Release, Product
Hikma launches Labetalol Hydrochloride Injection, USP in prefilled syringe
Press Release, Product
Hikma launches Icosapent Ethyl Capsules, 0.5g, in the US
Press Release, Product
Hikma launches Cefazolin for Injection, USP, in the US
Press Release, Product
Hikma expands impact in Canada with launches of new sterile injectable medicines
Press Release, Product
Hikma delivers a resilient underlying performance in 2022
Press Release, Financial Results
Hikma to present at 41st Annual J.P. Morgan Healthcare Conference
Press Release, Corporate
Hikma expands addiction therapy portfolio with the launch of Naloxone Hydrochloride Injection, USP, in prefilled syringe
Press Release, Product
Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa...
Press Release, Corporate